Aarti Drugs Ltd.
421.50-1.5 (-0.35%)
8 Sep, 12:00 AM
Income Statement
Abridged
Understanding Income Statement
Aarti Drugs Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.
Balance Sheet
Abridged
Understanding Balance Sheet
Aarti Drugs Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.
Cash Flow
Abridged
Understanding Cash Flow Statement
Aarti Drugs Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.
We don't have enough data to show Annual Consolidated Cash Flow data for Aarti Drugs Ltd.
Business Segment Analysis
FY End:
Mar 25
Aarti Drugs Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.
Capex
Pharmasuticals (100.0%)₹ 177.16 Cr
Revenue / Sales
Pharmasuticals (100.0%)₹ 2,387.03 Cr
Assets
Pharmasuticals (100.0%)₹ 2,574.68 Cr
Operating Income
Pharmasuticals (100.0%)₹ 234.45 Cr
Regional Segment Analysis
FY End:
Mar 25
Aarti Drugs Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.
Revenue / Sales
India (63.7%)₹ 1,521.70 CrOut of India (36.3%)₹ 865.33 Cr
Historical Segment Analysis
Track how Aarti Drugs Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.
Business
Frequently Asked Questions
What is the revenue of Aarti Drugs Ltd.?
The latest trailing twelve month revenue of Aarti Drugs Ltd. is ₹ 2,677.58 Cr, reflecting a 1-year growth of 10.54% and a 3-year CAGR of -0.95%. Annual and quarterly revenue trends are available in the Income Statement section.
What is the net profit of Aarti Drugs Ltd.?
The latest trailing twelve month net profit (PAT) of Aarti Drugs Ltd. is ₹ 191.18 Cr, with a 3-year earnings CAGR of 2.60%. Detailed profit history across annual and quarterly periods is in the Income Statement section.
What is the EBITDA of Aarti Drugs Ltd.?
The trailing twelve month EBITDA of Aarti Drugs Ltd. is approximately ₹ 262.61 Cr (based on an operating margin of 9.81%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.
What is the EPS of Aarti Drugs Ltd.?
The trailing twelve month Earnings Per Share (EPS) of Aarti Drugs Ltd. is 20.93. EPS trends across annual and quarterly periods are visible in the Income Statement section.
What is the debt level of Aarti Drugs Ltd.?
The debt-to-equity ratio of Aarti Drugs Ltd. stands at 0.37. The interest coverage ratio is 7.64x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.
What is the book value per share of Aarti Drugs Ltd.?
The estimated book value per share of Aarti Drugs Ltd. is 169.70 (derived from a P/B ratio of 2.48 and market price of ₹ 421.50), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.
What is the cash flow from operations of Aarti Drugs Ltd.?
The trailing twelve month operating cash flow of Aarti Drugs Ltd. is ₹ 222.41 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.
Does Aarti Drugs Ltd. report consolidated or standalone financials?
Aarti Drugs Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.